title: Mitochondrial Impairment in Cerebrovascular Endothelial Cells is Involved in the Correlation between Body Temperature and Stroke Severity.
abstract: Stroke is the second leading cause of death worldwide. The prognostic influence of body temperature on acute stroke in patients has been recently reported; however, hypothermia has confounded experimental results in animal stroke models. This work aimed to investigate how body temperature could prognose stroke severity as well as reveal a possible mitochondrial mechanism in the association of body temperature and stroke severity. Lipopolysaccharide (LPS) compromises mitochondrial oxidative phosphorylation in cerebrovascular endothelial cells (CVECs) and worsens murine experimental stroke. In this study, we report that LPS (0.1 mg/kg) exacerbates stroke infarction and neurological deficits, in the mean time LPS causes temporary hypothermia in the hyperacute stage during 6 hours post-stroke. Lower body temperature is associated with worse infarction and higher neurological deficit score in the LPS-stroke study. However, warming of the LPS-stroke mice compromises animal survival. Furthermore, a high dose of LPS (2 mg/kg) worsens neurological deficits, but causes persistent severe hypothermia that conceals the LPS exacerbation of stroke infarction. Mitochondrial respiratory chain complex I inhibitor, rotenone, replicates the data profile of the LPS-stroke study. Moreover, we have confirmed that rotenone compromises mitochondrial oxidative phosphorylation in CVECs. Lastly, the pooled data analyses of a large sample size (n=353) demonstrate that stroke mice have lower body temperature compared to sham mice within 6 hours post-surgery; the body temperature is significantly correlated with stroke outcomes; linear regression shows that lower body temperature is significantly associated with higher neurological scores and larger infarct volume. We conclude that post-stroke body temperature predicts stroke severity and mitochondrial impairment in CVECs plays a pivotal role in this hypothermic response. These novel findings suggest that body temperature is prognostic for stroke severity in experimental stroke animal models and may have translational significance for clinical stroke patients - targeting endothelial mitochondria may be a clinically useful approach for stroke therapy.
authors.affiliation: 1 Department of Physiology and Pharmacology,; 2 Experimental Stroke Core, Center for Basic and Translational Stroke Research.
authors.forename: Heng
authors.initials: H
authors.lastname: Hu
authors.affiliation: 1 Department of Physiology and Pharmacology.
authors.forename: Danielle N
authors.initials: DN
authors.lastname: Doll
authors.affiliation: 1 Department of Physiology and Pharmacology.
authors.forename: Jiahong
authors.initials: J
authors.lastname: Sun
authors.affiliation: 1 Department of Physiology and Pharmacology.
authors.forename: Sara E
authors.initials: SE
authors.lastname: Lewis
authors.affiliation: 3 Department of Medicine.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Wimsatt
authors.affiliation: 4 Office of Laboratory Animal Resources, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia, 26506 USA.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Kessler
authors.affiliation: 1 Department of Physiology and Pharmacology,; 2 Experimental Stroke Core, Center for Basic and Translational Stroke Research.
authors.forename: James W
authors.initials: JW
authors.lastname: Simpkins
authors.affiliation: 1 Department of Physiology and Pharmacology,; 2 Experimental Stroke Core, Center for Basic and Translational Stroke Research.
authors.forename: Xuefang
authors.initials: X
authors.lastname: Ren
keywords: Body Temperature; Endothelial Cells; Hypothermia; Impairment; Mitochondria; Severity; Stroke
references.citation: Mech Ageing Dev. 1981 May;16(1):97-104
references.pmid: 7253723
references.citation: Brain. 2007 Dec;130(Pt 12):3063-74
references.pmid: 17478443
references.citation: J Cereb Blood Flow Metab. 1992 Jan;12(1):2-11
references.pmid: 1345757
references.citation: Neurosci Lett. 1991 Nov 11;132(2):255-8
references.pmid: 1664505
references.citation: Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1158-72
references.pmid: 16115019
references.citation: Curr Pharm Des. 2007;13(22):2310-22
references.pmid: 17692002
references.citation: Exp Neurol. 2000 Jun;163(2):399-407
references.pmid: 10833314
references.citation: Neurosci Lett. 2011 Sep 1;501(3):123-7
references.pmid: 21435374
references.citation: Front Neurol Neurosci. 2013;32:122-8
references.pmid: 23859971
references.citation: Stroke. 2004 Jul;35(7):1720-5
references.pmid: 15155973
references.citation: Pathophysiology. 2005 Sep;12(2):85-95
references.pmid: 16023558
references.citation: Mech Ageing Dev. 2003 Dec;124(10-12):1047-58
references.pmid: 14659593
references.citation: Science. 1990 Feb 2;247(4942):571-4
references.pmid: 2154034
references.citation: Shock. 2008 Jan;29(1):119-26
references.pmid: 17621253
references.citation: J Neurol. 2011 Feb;258(2):302-7
references.pmid: 20878419
references.citation: Crit Care. 2013 Nov 13;17(6):R271
references.pmid: 24220071
references.citation: Vasc Health Risk Manag. 2012;8:333-8
references.pmid: 22701327
references.citation: NeuroRx. 2005 Jul;2(3):396-409
references.pmid: 16389304
references.citation: Circ Res. 1981 Mar;48(3):393-400
references.pmid: 7460212
references.citation: Nat Rev Immunol. 2011 Jun;11(6):389-402
references.pmid: 21597473
references.citation: Lancet. 2014 Jan 18;383(9913):245-54
references.pmid: 24449944
references.citation: Shock. 2008 Oct;30 Suppl 1:53-9
references.pmid: 18704008
references.citation: Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):16-26
references.pmid: 19029993
references.citation: J Rheumatol. 1994 Jan;21(1):80-3
references.pmid: 8151594
references.citation: Kidney Int. 2011 Jul;80(1):51-60
references.pmid: 21368743
references.citation: Cell. 2005 Feb 25;120(4):483-95
references.pmid: 15734681
references.citation: J Neurotrauma. 2009 Mar;26(3):313-23
references.pmid: 19216634
references.citation: J Vasc Res. 2014;51(3):175-89
references.pmid: 24862206
references.citation: Stroke. 1992 Dec;23(12):1812-6
references.pmid: 1448833
references.citation: Acta Neurol Scand. 1992 Jul;86(1):45-9
references.pmid: 1325729
references.citation: J Cereb Blood Flow Metab. 2002 Jan;22(1):29-38
references.pmid: 11807391
references.citation: Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):221-35
references.pmid: 22385116
references.citation: J Cereb Blood Flow Metab. 1996 May;16(3):474-80
references.pmid: 8621752
references.citation: Free Radic Biol Med. 2006 Mar 15;40(6):976-82
references.pmid: 16540393
references.citation: Stroke. 2015 Jan;46(1):132-6
references.pmid: 25424482
references.citation: Brain Behav Immun. 2013 Feb;28:188-95
references.pmid: 23207106
references.citation: J Clin Invest. 2013 Jul 1;:null
references.pmid: 23863629
references.citation: Circ Res. 2007 Mar 2;100(4):460-73
references.pmid: 17332437
references.citation: J Neuroinflammation. 2011 Nov 24;8:164
references.pmid: 22114895
references.citation: Stroke. 1998 Feb;29(2):529-34
references.pmid: 9472901
references.citation: Acta Neurol Scand. 2005 May;111(5):329-32
references.pmid: 15819713
references.citation: J Physiol. 2014 Jun 15;592(12):2549-61
references.pmid: 24665093
references.citation: Stroke. 2015 Jun;46(6):1681-9
references.pmid: 25922503
references.citation: Front Neurol. 2011 Dec 27;2:80
references.pmid: 22207862
references.citation: Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H492-501
references.pmid: 20525873
references.citation: Parkinsons Dis. 2011;2011:327089
references.pmid: 21603177
references.citation: Curr Pharm Des. 2008;14(4):359-70
references.pmid: 18289062
references.citation: J Neuroinflammation. 2010 Mar 04;7:15
references.pmid: 20202211